Amidst a backdrop of global economic uncertainties and shifting market dynamics, the Swedish stock market presents unique opportunities for investors looking to enhance their portfolios with dividend ...

BioGaia publishes the interim report for the fourth quarter 2025 on Thursday, February 12, 2026, at 08:00 a.m. CET, followed by an audiocast at 09:30 a.m. CET. Mikaela Idermark Stern, Corporate ...

We're going to check out a few of the best picks from our screener tool. Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization of ...

BioGaia, a Swedish biotechnology company that develops, markets and sells probiotic products, and Nestlé have signed agreements to extend the collaboration in the field of infant nutrition products.

BioGaia's probiotics have received top ratings and the company has seen rapid growth, but concerns are raised about the company's ability to maintain this amidst leadership changes. The company ...

Net sales amounted to SEK 326.6 million (304.0), an increase of SEK 22.7 million, or an increase of 7% (excluding foreign exchange effects an increase of 14%). Net sales in the Pediatrics segment ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Prior to the new review seven meta-analyses, evaluating different probiotics as well as non-probiotic treatments, have come to the same conclusion; that L.

Swedish probiotic biotech company BioGaia is making headway in its short-term mission to attain profitability, reporting a 39 percent increase in sales to SEK 16.4 million for 3Q 2005. Operating ...